Question 1

What is the catalog number for FHT-1015?

Accepted Answer

The catalog number for FHT-1015 is M35753.

Question 2

What sizes are available for FHT-1015?

Accepted Answer

FHT-1015 is available in the following size(s): 1 g, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg.

Question 3

How many pack sizes does FHT-1015 come in?

Accepted Answer

FHT-1015 is available in 8 different pack sizes.

Question 4

Is FHT-1015 in stock?

Accepted Answer

FHT-1015 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is FHT-1015 used for?

Accepted Answer

FHT-1015 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with potential anticancer activity for the study of cancer and inflammation.

Question 6

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

Question 7

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 8

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

FHT-1015

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

MEF2A Blocking Peptide

MEF2A Blocking Peptide

MEF2A Blocking Peptide

SP1 antibody

RAF1, phosphorylated (Ser296) (RAF Proto-oncogene Serine/Threonine-protein Kinase, Proto-oncogene c-RAF, Raf-1, C-RAF, cRaf, RAF) (FITC) discontinued

BRS3, ID (BRS3, Bombesin receptor subtype-3) (MaxLight 750)